title: Mucormycosis and hemopoietic transplants.
abstract: Mucormycosis is becoming recognized as a serious complication in patients undergoing hemopoietic transplantation (HT), because it is a major cause of morbidity and mortality. In our institution 4 cases of mucormycosis in post-HT period among 345 patients undergoing HT were diagnosed between 1984 and 1997. We studies the clinical characteristics of these cases and we conclude that mucormycosis is not a common infection in patients undergoing HT but that it is followed by a high morbidity and mortality. Maintained neutropenia is the most important risk factor.
authors.forename: F J
authors.initials: FJ
authors.lastname: Peñalver
authors.forename: R
authors.initials: R
authors.lastname: Romero
authors.forename: R
authors.initials: R
authors.lastname: Forés
authors.forename: R
authors.initials: R
authors.lastname: Cabrera
authors.forename: M
authors.initials: M
authors.lastname: Briz
authors.forename: M
authors.initials: M
authors.lastname: Fernández
mesh_terms: D000328:Adult; D005260:Female; D006402:Hematologic Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D009090:Mucorales / Q000302:isolation & purification*; D009091:Mucormycosis / Q000209:etiology* / Q000503:physiopathology*